AA
Ancora Advisors’s Charles River Laboratories CRL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.65K | Buy |
57
+1
| +2% | +$152 | ﹤0.01% | 1385 |
|
2025
Q1 | $8.43K | Sell |
56
-330
| -85% | -$49.7K | ﹤0.01% | 1323 |
|
2024
Q4 | $71.3K | Buy |
386
+1
| +0.3% | +$185 | ﹤0.01% | 913 |
|
2024
Q3 | $75.8K | Sell |
385
-10,060
| -96% | -$1.98M | ﹤0.01% | 877 |
|
2024
Q2 | $2.16M | Sell |
10,445
-6,995
| -40% | -$1.45M | 0.05% | 254 |
|
2024
Q1 | $4.73M | Sell |
17,440
-179
| -1% | -$48.5K | 0.11% | 168 |
|
2023
Q4 | $4.17M | Sell |
17,619
-696
| -4% | -$165K | 0.1% | 176 |
|
2023
Q3 | $3.59M | Sell |
18,315
-6,136
| -25% | -$1.2M | 0.1% | 179 |
|
2023
Q2 | $5.14M | Buy |
24,451
+13,885
| +131% | +$2.92M | 0.14% | 141 |
|
2023
Q1 | $2.13M | Sell |
10,566
-2,690
| -20% | -$543K | 0.06% | 234 |
|
2022
Q4 | $2.89M | Buy |
13,256
+8,100
| +157% | +$1.77M | 0.08% | 202 |
|
2022
Q3 | $1.02M | Buy |
5,156
+4,500
| +686% | +$886K | 0.03% | 337 |
|
2022
Q2 | $140K | Sell |
656
-70
| -10% | -$14.9K | ﹤0.01% | 833 |
|
2022
Q1 | $206K | Sell |
726
-9,779
| -93% | -$2.77M | 0.01% | 770 |
|
2021
Q4 | $3.96M | Sell |
10,505
-7,580
| -42% | -$2.86M | 0.09% | 190 |
|
2021
Q3 | $7.46M | Sell |
18,085
-2,431
| -12% | -$1M | 0.19% | 115 |
|
2021
Q2 | $7.59M | Sell |
20,516
-330
| -2% | -$122K | 0.2% | 117 |
|
2021
Q1 | $6.04M | Sell |
20,846
-1,710
| -8% | -$496K | 0.17% | 135 |
|
2020
Q4 | $5.64M | Sell |
22,556
-230
| -1% | -$57.5K | 0.18% | 145 |
|
2020
Q3 | $5.16M | Sell |
22,786
-15,930
| -41% | -$3.61M | 0.2% | 119 |
|
2020
Q2 | $6.75M | Sell |
38,716
-23,520
| -38% | -$4.1M | 0.28% | 89 |
|
2020
Q1 | $7.86M | Buy |
62,236
+4,140
| +7% | +$523K | 0.36% | 74 |
|
2019
Q4 | $8.88M | Sell |
58,096
-14
| -0% | -$2.14K | 0.33% | 89 |
|
2019
Q3 | $7.69M | Buy |
58,110
+11,400
| +24% | +$1.51M | 0.34% | 93 |
|
2019
Q2 | $9.28M | Buy |
+46,710
| New | +$9.28M | 0.42% | 83 |
|